lilly compounded tirzepatide releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity FDA confirms tirzepatide shortage is

Tirzepatide binds to GIP and GLP-1 receptors in the hypothalamus and gastrointestinal tract, triggering hormonal cascades that suppress ghrelin, extend postprandial satiety, and delay the gastric emptying rate by 7090 minutes per meal

Their responses reveal a shift: Longevity is becoming less about chasing superhuman status and more about evidence-based habits that meet people where they are, looking to live healthier today and for as long as possible

Presented for research literature review only Grover S et al

GLP-1 drugs have more than three times the crude, addressable market

Now Joe Rogan is facing a major backlash on social media